Superior mesenteric
Superior Mesenteric Artery Syndrome (SMAS) is a rare, potentially life-threatening gastro-vascular disorder characterized by the compression of the third part of the duodenum between the abdominal aorta and the overlying superior mesenteric artery. This condition can lead to partial or complete blockage of the duodenum, causing a range of gastrointestinal symptoms. The syndrome is also known as Wilkie's syndrome, cast syndrome, mesenteric root syndrome, or chronic duodenal ileus.
Causes and Risk Factors[edit | edit source]
The primary cause of SMAS is a reduction in the angle between the superior mesenteric artery and the abdominal aorta, which compresses the duodenum. This can be due to a variety of factors, including significant weight loss, anatomical variations, surgical alterations of the anatomy, or conditions that lead to rapid growth spurts. Other risk factors include spinal deformities and wearing of tight corsets that can alter the normal anatomical relations in the abdomen.
Symptoms[edit | edit source]
Symptoms of SMAS can vary but often include severe abdominal pain, nausea, vomiting, fullness after eating, and weight loss. In severe cases, it can lead to malnutrition and weight loss due to the inability to properly digest and absorb nutrients.
Diagnosis[edit | edit source]
Diagnosis of SMAS typically involves a combination of patient history, physical examination, and imaging studies. Computed tomography (CT) scans, magnetic resonance imaging (MRI), and upper gastrointestinal series with barium are commonly used to visualize the compression of the duodenum and the narrowing angle between the superior mesenteric artery and the abdominal aorta.
Treatment[edit | edit source]
Treatment options for SMAS range from conservative management to surgical intervention. Nutritional support, including enteral nutrition through a nasogastric tube or parenteral nutrition, is often the first step in management. In cases where conservative treatment fails, surgical options such as duodenojejunostomy or gastrojejunostomy may be considered to bypass the obstruction.
Prognosis[edit | edit source]
The prognosis for individuals with SMAS varies depending on the severity of the condition and the success of treatment. With appropriate management, many patients can recover completely and lead normal lives. However, without treatment, SMAS can lead to serious complications, including malnutrition, electrolyte imbalances, and even death.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD